For the last reported quarter, it was expected that castle biosciences, inc. Make sure to utilize our earnings esp filter to uncover the best stocks to buy or sell before they've reported.
Is castle biosciences inc stock public?
Castle biosciences stock buy or sell. Castle biosciences inc is a diagnostics & research business based in the us. Castle biosciences is a diagnostics & research business based in the us. The castle biosciences inc stock price is 51.68 usd today.
There are few to no technical positive signals at the moment. The stock was sold at an average price of $61.05, for a total value of $271,428.30. In related news, director daniel bradbury sold 4,446 shares of castle biosciences stock in a transaction dated thursday, november 4th.
Yes, castle biosciences inc is a publicly traded company. Specifically, they have bought $0.00 in company stock and sold $4,163,672.00 in company stock. Learn more on cstl's analyst rating history
127 rows insiders have sold a total of 2,365,335 castle biosciences shares in the last. How to buy castle biosciences inc stock online? According to the issued ratings of 6 analysts in the last year, the consensus rating for castle biosciences stock is buy based on the current 6 buy ratings for cstl.
They sold a total of 1,011,972 shares worth more than $67,862,016.92. Castle biosciences reported revenue of $23.5 million, slightly above the $23.0 million consensus estimate, but its loss per share of $0.47 was worse. Cstl) is owned by 82.53% institutional shareholders, 18.17% castle biosciences insiders, and 0.00% retail investors.
3 wall street analysts covering (nasdaq: They sold at prices ranging from $52.47 to $53.04 to raise a total of $861,463 from the stock sale. Castle biosciences shares (cstl) are listed on the nasdaq and all prices are listed in us dollars.
Zacks investment research raised shares of castle biosciences from a sell rating to a hold rating in a research report on tuesday, october 26th. The stock has a consensus analyst rating of buy. a buy rating indicates that analysts believe cstl will outperform the market and that investors should add to their positions of castle biosciences. Healthquest partners lp sofinnova is the largest individual castle biosciences shareholder, owning 1.43m shares representing 5.70% of the company.
Use the zacks rank and style scores to find out is cstl is right for your portfolio. Check out our latest analysis for castle biosciences Most recently, daniel bradbury sold 5,554 shares of the business's stock in a transaction on monday, november 8th.
In the last ninety days, daniel bradbury has sold $1,230,739.00 of castle biosciences stock. Canaccord genuity raised their price objective on shares of castle biosciences from $47.00 to $52.00 and gave the stock a buy rating in a research report on friday, september 3rd. Investors may wish to note that the independent chairman of the board of castle biosciences, inc., daniel bradbury, recently netted us$79k from selling stock, receiving an average price of us$62.94.however we note that the sale only shrunk their holding by 0.4%.
In the past three months, castle biosciences insiders have sold more of their company's stock than they have bought. What is the castle biosciences inc stock quote today? Cstl) stock is to strong buy cstl stock.
During the last year, castle biosciences insiders bought shares 1 times. In total, 306 thousand shares were bought and sold for approximately $27.45 million. View the latest ratings for cstl.
Castle biosciences insider transactions over the last year in the last twelve months, the biggest single sale by an insider was when the chief business. Out of 3 analysts, 2 ( 66.67% ) are recommending cstl as a strong buy, 1 ( 33.33% ) are recommending cstl as a buy, 0 ( 0% ) are recommending cstl as a hold, 0 ( 0% ) are recommending cstl as a sell, and 0 ( 0% ) are recommending cstl as a strong sell. So shareholders might well want to know whether insiders have been buying or selling shares in castle biosciences, inc.
Most investors know that it is quite permissible for company leaders, such as. During the last year, insiders at the sold shares 72 times. Castle biosciences stocks (cstl.us) are listed on the nasdaq and all prices are listed in us dollars.
Should i buy castle biosciences (cstl)? They purchased a total of 1,160 shares worth more than $21,541.20. Castle biosciences currently has 6 buy ratings from wall street analysts.
Maetzold still owns a total of 439,392 shares of castle biosciences worth, $22,947,247.00. The shares were sold at an average price of.
